Global Rheumatoid Arthritis Drugs Market 2018-2022

Global Rheumatoid Arthritis Drugs Market 2018-2022

About this market

The use of biologics and biosimilars for the treatment of RA is likely to help the market grow. Unlike synthetic DMARDs, biologics have targeted mechanisms of action and serve as promising molecules for the successful treatment of RA. Technavio’s analysts have predicted that the rheumatoid arthritis drugs market will register a CAGR of close to 8% by 2022.

Market Overview

Increasing need for affordable biologics for rheumatoid arthritis

Unlike conventional DMARDs, such as nonsteroidal anti-inflammatory drugs (NSAIDs) that simply provide symptomatic relief, biologics are considered a more effective medication for management of rheumatoid arthritis.

Low access to healthcare due to social stigma

Social stigma associated with RA mainly due to physical deformities and functional limitations in RA patients. Various strategies are being adopted to tackle social stigma at the patient level.

For the detailed list of factors that will drive and challenge the growth of the rheumatoid arthritis drugs market during the 2018-2022, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Amgen and Novartis the competitive environment is quite intense. Factors such as the use of biologics and biosimilars for the treatment of RA and increasing need for affordable biologics for rheumatoid arthritis, will provide considerable growth opportunities to rheumatoid arthritis drugs manufactures. AbbVie, Amgen, Novartis, Pfizer, UCB Pharma, and Johnson & Johnson are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. Many established rheumatoid arthritis drug companies are vying for their share of the global rheumatoid arthritis drugs market, and players must differentiate themselves to gain vital traction over their competitors.’


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Rheumatoid Arthritis Drugs Market 2018-2022

Technavio recognizes the following companies as the key players in the global rheumatoid arthritis drugs market: AbbVie, Amgen, Novartis, Pfizer, UCB Pharma, and Johnson & Johnson.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the use of biologics and biosimilars for the treatment of RA.”

According to the report, one of the major drivers for this market is the increasing need for affordable biologics for rheumatoid arthritis.

Further, the report states that one of the major factors hindering the growth of this market is the low access to healthcare due to social stigma.

Companies Mentioned

AbbVie

Amgen

Johnson & Johnson

Novartis

Pfizer

UCB Pharma

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global immunology market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline molecules for RA
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ bn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by type of molecule
    • Segmentation by type of molecule
      • Table Type of molecule - Market share 2017-2022 (%)
    • Comparison by type of molecule
      • Table Comparison by type of molecule
    • Biologics - Market size and forecast 2017-2022
      • Table Biologics - Market size and forecast 2017-2022 ($ bn)
      • Table Biologics - Year-over-year growth 2018-2022 (%)
    • Small molecules - Market size and forecast 2017- 2022
      • Table Small molecules - Market size and forecast 2017-2022 ($ bn)
      • Table Small molecule - Year-over-year growth 2018-2022 (%)
    • Market opportunity by type of molecule
      • Table Market opportunity by type of molecule
  • Market segmentation by type of RA
    • Segmentation by type of RA
    • Seropositive RA
    • Seronegative RA
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ bn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ bn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ bn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • High cost of RA drugs
    • Use of biologics/biosimilars for treatment of RA
    • Use of gene therapy for RA treatment
    • Market dominance by TNF-alpha inhibitors
    • Need for rheumatologists
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie
      • Table AbbVie - Overview
      • Table AbbVie - Business segments
      • Table AbbVie - Organizational developments
      • Table AbbVie - Geographic focus
      • Table AbbVie - Segment focus
      • Table AbbVie - Key offerings
    • Amgen
      • Table Amgen - Overview
      • Table Amgen - Business segments
      • Table Amgen - Organizational developments
      • Table Amgen - Geographic focus
      • Table Amgen - Segment focus
      • Table Amgen - Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson - Overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Organizational developments
      • Table Johnson & Johnson - Geographic focus
      • Table Johnson & Johnson - Segment focus
      • Table Johnson & Johnson - Key offerings
    • Novartis
      • Table Novartis - Overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
    • Pfizer
      • Table Pfizer - Overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
    • UCB Pharma
      • Table UCB Pharma - Overview
      • Table UCB Pharma - Business segments
      • Table UCB Pharma - Organizational developments
      • Table UCB Pharma - Geographic focus
      • Table UCB Pharma - Segment focus
      • Table UCB Pharma - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook